Open AccessComparison of gonadotropin-releasing hormone agonist with GnRH antagonist in polycystic ovary syndrome patients undergoing in vitro fertilization cycle: Retrospective analysis from a tertiary center and review of literature
Author(s) -
Neeta Singh,
Moumita Naha,
Neena Malhotra,
Kusum Lata,
Perumal Vanamail,
Abnish Tiwari
Publication year - 2014
Publication title -
journal of human reproductive sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.484
H-Index - 31
eISSN - 0974-1208
pISSN - 1998-4766
DOI - 10.4103/0974-1208.130852
Subject(s) - ovarian hyperstimulation syndrome , polycystic ovary , gonadotropin releasing hormone antagonist , in vitro fertilisation , controlled ovarian hyperstimulation , medicine , agonist , pregnancy rate , antagonist , gonadotropin releasing hormone agonist , gynecology , gonadotropin releasing hormone , biology , pregnancy , hormone , luteinizing hormone , receptor , insulin resistance , genetics , insulin
Polycystic ovary syndrome (PCOS) is one of the most common infertility factor for which women are enrolled in in vitro fertilization (IVF) technique. In the recent years, gonadotropin releasing hormone antagonist protocol has emerged as the protocol of choice for controlled ovarian hyperstimulation in these patients.